Abhay Singh, MD MPH
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Eltrombopag as a Novel Therapeutic Approach for Low-risk MDS and CMML With TET2 Mutations (NCT06630221) | Abhay Singh, MD MPH | 2025-06-17 |
Track Abhay Singh, MD MPH automatically
Every clearance here is in the API, with alerts when new ones post.